Table 1 Clinical characteristics of systemic lupus erythematosus patients and age- and gender-matched healthy controls
Parameters | SLE patients | HCs |
|---|---|---|
(n = 14) | (n = 12) | |
Age (years) | 41.0 (26.0–52.0) | 43.0 (30.0–51.0) |
Gender (% female) | 100 | 100 |
Disease duration (years) | 4.6 (2.2–11.4) | - |
SLEDAI | 4.0 (2.5–6.0) | - |
SLICC | 0.0 (0.0–1.0) | - |
dsDNA (% ever positive) | 79.0 | - |
dsDNA (IU/mL) | 31.5 (10.8–396.8) | - |
Clinical features (no. of patients) | ||
Nephritis | 0 | - |
Arthritis | 4 | - |
Rash | 7 | - |
Serositis | 2 | - |
Leukopenia | 6 | - |
Oral ulcers | 4 | - |
Vasculitis | 1 | - |
Treatment (no. of patients) | ||
None | 2 | - |
Hydroxychloroquine | 6 | - |
Azathioprine | 4 | - |
Cyclophosphamide | 1 | - |
Mycophenolate mofetil | 3 | - |
Prednisone | 12 | - |